Bone marrow purging with mafosfamide ? A critical survey
- 1 November 1989
- journal article
- Published by Springer Nature in Blut: Zeitschrift für die Gesamte Blutforschung
- Vol. 59 (5), 432-441
- https://doi.org/10.1007/bf00349064
Abstract
Autologous bone marrow transplantation (ABMT) is increasingly used to consolidate remissions, primarily in hematological disease. Various purging strategies have been developed to minimize the risk of reimplantation of tumor cells with the bone marrow autotransplant. Pharmacological purging with the oxazaphosphorine derivative mafosfamide has been studied extensively, and recent clinical data suggest that purging with mafosfamide may translate into superior remission duration if compared to nonpurged ABMT in acute leukemia. Chemical and experimental data relevant to mafosfamide-purging and clinical results are reviewed, with special emphasis on safety aspects.Keywords
This publication has 54 references indexed in Scilit:
- ACCELERATION OF NEUTROPHILIC GRANULOCYTE RECOVERY AFTER BONE-MARROW TRANSPLANTATION BY ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTORThe Lancet, 1988
- Cellular and molecular aspects of neoplastic progression in the mammary glandEuropean Journal of Cancer and Clinical Oncology, 1988
- The regulation of hematopoiesis following bone marrow transplantationThe International Journal of Cell Cloning, 1987
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Infections in bone marrow transplant recipientsThe Journal of Pediatrics, 1986
- EVALUATION OF THE USE OF HIGH-DOSE CYTOREDUCTION WITH AUTOLOGOUS MARROW RESCUE IN VARIOUS MALIGNANCIESTransplantation, 1986
- Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrowRevue Française de Transfusion et Immuno-hématologie, 1985
- Pharmacological purging of bone marrow with drugs other than cyclophosphamide derivativesRevue Française de Transfusion et Immuno-hématologie, 1985
- Human bone marrow processing in view of further in vitro treatment and cryopreservationRevue Française de Transfusion et Immuno-hématologie, 1985
- Oxazaphosphorines as biological response modifiers-experimental and clinical perspectivesCancer Treatment Reviews, 1985